Friday, September 5, 2008

New Study Indicates Further Dangers of Conventional Hormone Replacement Therapy

Even the mainstream medical establishment has finally come around and admitted that the use of synthetic hormone replacement therapy in women is hazardous. They initially stated that the use of such drugs was only linked to increased risk of breast cancer in women using them for at least five years. However, new evidence indicates that shorter usage periods can significantly increase risk for certain types of cancers after only three years. It is obvious that the use of these artificial forms of hormones is not a good choice for health-conscious women, regardless of the length of exposure.

The "one size fits all" approach to hormonal balance that is the foundation of most HRT regimens is obviously a huge mistake. One of the concerns is that such therapies assume that all women are estrogen-deficient, despite the fact that this is typically not the case. The use of synthetic estrogen does help relieve some hormonal symptoms, but never gets to the root of the concern and in fact may cause more health concerns down the road. The use of a high-quality, natural hormone replacement product will address the problem of progesterone deficiency that is overlooked by conventional HRT, and will provide natural hormonal balance in a form that is gentle to the body, and easily recognized and assimilated for maximum safety and efficiency. There are many natural ways of dealing with hormonal changes. Do not be duped into thinking that the use of synthetic HRT, even for a short time, is necessary or safe, regardless of the advice of many well-meaning but misinformed healthcare practitioners.


Hormone Replacement Therapy Boosts Risk of Breast Cancer by 400 Percent
by David Gutierrez

(NaturalNews) Hormone replacement therapy (HRT) increases women's risk of lobular breast cancer by four times after only three years, according to a study published in the journal Cancer Epidemiology, Biomarkers and Prevention.

"Previous research indicated that five or more years of combined hormone-therapy use was necessary to increase overall breast cancer risk," said lead researcher Christopher Li of the Fred Hutchinson Cancer Research Center. "Our study ... suggests that a significantly shorter length of exposure to such hormones may confer an increased risk."

Researchers suggested that the longer time period found in prior studies arose from the fact that those studies looked only at breast cancer in general, while the current study looked specifically at lobular cancers.

Lobular breast cancer accounts for approximately 10 percent of invasive breast cancers, while ductal breast cancer, in which tumors form in the breast's milk ducts, accounts for much of the rest.

In the current study, researchers questioned 1,500 post-menopausal women in western Washington about their use of HRT. Women who were currently taking HRT had three times the cancer rate as women who were not undergoing the therapy. Those who had been taking HRT drugs for three years or more had four times the risk.

The researchers noted that the occurrence of lobular cancer in the United States increased by 52 percent between 1987 and 1999, while the incidence of ductal-lobular cancer rose by 96 percent. In the same time period, the occurrence of ductal cancer rose by only 3 percent.

In 2002, the results of the Women's Health Initiative study first showed a link between HRT and increased breast cancer risk, leading to a sharp drop in the prevalence of HRT. Between 2001 and 2004, the researchers noted, breast cancer rates in the United States fell by 8.6 percent.

http://www.naturalnews.com/023893.html

No comments:

Post a Comment